Plastic Surgery Doctors in Dayton, OH Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

James Apesos, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5441 Far Hills Ave, Dayton, OH 45429 Phone: 937-435-0031    Fax: 937-435-3055

Dr. Ravi Surya Devara, MD Plastic Surgery - Surgery of the Hand Medicare: Not Enrolled in Medicare Practice Location: 550 W David Pkwy, Dayton, OH 45429 Phone: 937-299-2331    Fax: 937-299-2331

Christopher John Danis, MD Plastic Surgery - Surgery of the Hand Medicare: Medicare Enrolled Practice Location: 2350 Miami Valley Dr, Ste 310, Dayton, OH 45459 Phone: 937-435-4263    Fax: 937-298-9459

Dr. Carlos Francisco Sanchez-navarro Jr., M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1 Wyoming St Fl 7, Dayton, OH 45409 Phone: 937-208-2485

Keith Perrine, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5250 Far Hills Ave, 110, Dayton, OH 45429 Phone: 937-432-9810    Fax: 937-432-9815

Dr. Michael Colin Rymer, M.D. Plastic Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 2350 Miami Valley Dr, Suite 310, Dayton, OH 45459 Phone: 937-435-4263    Fax: 937-298-9459

News Archive

New test to better predict heart attack risk in women

The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.

Physicians urge Senators to repeal Medicare cuts

The U.S. Senate's failure to act before today's 21 percent Medicare physician payment cut has put seniors at grave risk of reduced access to health care and choice of physician.

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).

Poor diet among infants' mothers linked to rise in Congenital Zika Syndrome cases

Congenital Zika Syndrome (CZS) refers to a collection of developmental malformations associated with Zika virus (ZIKV) congenital infection.

Velano Vascular announces FDA approval of new blood-draw technology

Velano Vascular today announced that the U.S. Food and Drug Administration has granted marketing clearance for a new technology that provides an innovative approach to one of the most common procedures in medicine – the in-hospital blood draw.

Read more Medical News

› Verified 2 days ago